Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age. - Vigil CE; Tan W; Deeb G; Sait SN; Block AW; Starostik P; Griffiths EA; Thompson JE; Greene JD; Ford LA; Wang ES; Wetzler M (Leukemia research, 2013)